medical device investing Accuray Closes TCW Transaction, Strengthening Balance Sheet to Support Long-Term Value Growth
medical device investing Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026
medical device investing Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
medical device investing Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
medical device investing Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
medical device investing Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments
medical device investing Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026
medical device investing Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
medical device investing Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026
SAGA Metals Reports More Significant Assays Including 109.1 m at 49.88% Fe2O3, 8.53% TiO2, 0.316% V2O5 at the Radar Critical Minerals Project
SAGA Metals Reports More Significant Assays Including 109.1 m at 49.88% Fe2O3, 8.53% TiO2, 0.316% V2O5 at the Radar Critical Minerals Project
Metalsource Mining Receives $1.38 Million from Eric Sprott Warrant Exercise as Silver Hill Gold-Silver Exploration Advances